Glucosaminylmuramyl dipeptide

Glucosaminylmuramyl dipeptide (GMDP) is a synthetic analogue of muramil-dipeptide. Glucosaminylmuramyl dipeptide inhibits 5'-nucleotidase activity. Glucosaminylmuramyl dipeptide produces marked antitumor effect. Glucosaminylmuramyl dipeptide can be used in sepsis research[1][2].

Product Specifications

CAS Number

[70280-03-4]

Product Name Alternative

GMDP

UNSPSC

12352005

Target

CD73; Drug Derivative

Related Pathways

Immunology/Inflammation; Others

Applications

Neuroscience-Neuromodulation

Field of Research

Cancer; Cardiovascular Disease

Smiles

CC(N[C@@H](C=O)[C@@H](O[C@H](C)C(N[C@@H](C)C(N[C@@H](C(N)=O)CCC(O)=O)=O)=O)[C@]([C@H](O)CO)([H])O[C@H]1[C@@H]([C@H]([C@@H]([C@H](O1)CO)O)O)NC(C)=O)=O

Molecular Formula

C27H45N5O16

Molecular Weight

695.67

References & Citations

[1]Boudagov R, et al. Preventive treatment of combined radiation injuries[C]//IRPA9: 1996 international congress on radiation protection. Proceedings. Volume 4. 1996: 157-159.|[2]Balitsky KP, et al. Glucosaminylmuramyl dipeptide-induced changes in murine macrophage metabolism. Int J Immunopharmacol. 1989;11 (5) :429-34.